Once available, a vaccine may only work on 50-70% of patients, and some people will resist taking it.
Repurposing existing drugs could produce life-saving treatment in a matter of months.
We must find an effective treatment patients can take immediately after infection, before hospitalization becomes necessary.
“Testing the top antiviral drugs must be our #1 priority. It is critical to raise funds to enable this testing to take place as soon as possible”